Managing POTS
POTS is highly treatable. A stepwise, evidence-based approach addressing lifestyle first, then medication, achieves significant improvement in the majority of patients. The aim is functional recovery — not just symptom suppression.
Stepwise Treatment Strategy
Treatment should be personalised and stepwise. Non-pharmacological measures are the cornerstone of POTS management — many patients achieve significant improvement with lifestyle modification alone. Medication is additive, not a substitute for behavioural change.
Education, salt/fluid loading, sleep positioning
Always firstPhysical counter-manoeuvres + compression garments
Add earlyStructured exercise rehabilitation (Levine Protocol)
CornerstonePharmacological treatment (subtype-guided)
If neededSpecialist referral / MDT management
Complex casesTargets of Care
Review patients at 6–8 weeks. Most will show improvement with non-pharmacological measures alone. Do not rush to medication.
Lifestyle & Behavioural Measures
Education & Explanation
First Line- Explain POTS mechanism to patient — often very reassuring
- Reassure: POTS is not life-threatening; most improve significantly
- Empower patient with self-management strategies
- Provide written resources (POTS UK, StopFainting)
- Explain the postural component — why lying flat provides relief
Salt & Fluid Loading
First Line- Target fluid intake: 2–3 litres per day
- Salt intake: 8–10g/day (liaise with dietitian)
- Salt tablets (1–2g TDS with meals) if dietary increase insufficient
- Electrolyte drinks (ORS/sports drinks) during activity
- Avoid diuretics, alcohol, and excess caffeine
- Contraindicated in hypertension or heart failure — check BP
Physical Counter-Manoeuvres
First Line- Leg crossing & tensing (reduces venous pooling acutely)
- Squatting (immediate HR reduction)
- Toe raises / calf pumping before standing
- Bending forward from the waist
- Teach patient to use these at symptom onset
Compression Garments
First Line- Full-length compression tights preferred over stockings alone
- At least 30–40 mmHg compression
- Abdominal binders helpful for abdominal pooling
- Worn during waking hours
- Stockings alone (knee-high) less effective
Exercise Rehabilitation
Key Intervention- Deconditioning worsens POTS — exercise is cornerstone of recovery
- Start with recumbent/horizontal exercise: rowing, swimming, cycling
- Avoid upright exercise initially (worsens symptoms)
- Levine Protocol: structured 3-month recumbent reconditioning programme
- Progress to upright exercise as tolerated
- Target 30 min aerobic + 20 min resistance training, 3–5×/week
- Enlist physiotherapist with POTS/dysautonomia experience
Sleep & Positional Strategies
Adjunctive- Elevate head of bed 10–15 cm (not just pillow — whole bed)
- Reduces overnight diuresis and maintains volume
- Avoid prolonged lying flat during the day
- Regular sleep schedule; avoid sleep deprivation
Dietary Modifications
Adjunctive- Eat small, frequent meals rather than large ones
- Avoid high-carbohydrate meals (splanchnic pooling)
- Consider low-FODMAP if GI symptoms prominent
- Gluten-free trial if coeliac antibodies positive
- Limit alcohol — vasodilatory effect worsens POTS
The Levine Exercise Protocol
Developed at UT Southwestern, this 3-month structured reconditioning programme is the most evidence-supported intervention for POTS. It begins with horizontal exercise (rowing, recumbent cycling) and progressively moves to upright activity as tolerance builds.
Month 1
Horizontal Phase
Rowing, swimming, recumbent cycling 3×/week. Resistance 2×/week (lower body). 30 min per session.
Month 2
Transition Phase
Introduce upright cycling with back support. Increase to 4×/week. Add upper body resistance.
Month 3
Upright Phase
Walking, upright cycling, elliptical. 5×/week aerobic + 3×/week resistance. Build to full activity.
Medication Options
Medication is additive to non-pharmacological measures. Subtype identification guides drug selection. Always start at the lowest dose.
Prescribing note: Several medications used in POTS are off-label. Discuss with patient and document consent. Clinical decisions must be based on individual patient circumstances.
| Drug | Dose | Mechanism & Indication | Cautions | Evidence |
|---|---|---|---|---|
Fludrocortisone | 0.05–0.2 mg daily | Mineralocorticoid — increases sodium & water retention Hypovolaemic POTS; inadequate response to salt/fluid | Monitor BP, potassium. Avoid in hypertension. Not in hyperadrenergic POTS. | Moderate |
Propranolol (low dose) | 10–40 mg TDS/QDS | Non-selective beta-blocker — reduces HR on standing Hyperadrenergic POTS; HR-dominant symptoms | Avoid in asthma. May worsen fatigue. Low dose only — high doses worsen symptoms. | Moderate |
Ivabradine | 2.5–7.5 mg BD | If-channel blocker — selective sinus rate reduction Tachycardia-dominant POTS; intolerance to beta-blockers | Contraindicated in acute HF, sick sinus, severe hepatic impairment. Off-label use. | Moderate (growing evidence base) |
Midodrine | 2.5–10 mg TDS | Alpha-1 agonist — peripheral vasoconstriction, reduces venous pooling Neuropathic POTS; orthostatic symptoms despite first-line treatment | Supine hypertension — do not take within 4 hours of lying down. Last dose before 6pm. | Good |
Pyridostigmine | 30–60 mg BD–TDS | Acetylcholinesterase inhibitor — enhances autonomic ganglionic transmission Neuropathic POTS; autoimmune POTS | GI side effects (nausea, diarrhoea). Avoid in asthma, bowel obstruction. | Moderate |
Clonidine | 0.05–0.2 mg BD | Central alpha-2 agonist — reduces sympathetic outflow Hyperadrenergic POTS specifically | Sedation, dry mouth. Rebound hypertension on abrupt withdrawal. | Limited (specialist use) |
SSRIs / SNRIs | Various | Serotonergic modulation of sympathetic tone; treat comorbid anxiety/depression POTS with anxiety comorbidity; post-viral POTS | Monitor BP. Some SSRIs may worsen tachycardia initially. | Limited |
Low-dose Naltrexone | 1.5–4.5 mg at night | Immunomodulatory; emerging evidence in autoimmune POTS Post-COVID POTS; autoimmune POTS; specialist centre use | Off-label. Limited evidence. Avoid in opioid dependence. | Emerging |
POTS in Special Contexts
Post-COVID POTS
A distinct phenotype of POTS increasingly seen following COVID-19 infection. Onset typically 1–3 months post-infection. May involve autoimmune mechanisms (mast cell activation, autoantibodies). Standard POTS management applies; low-dose naltrexone or LDN being investigated. Most improve over 12–18 months.
POTS in hEDS
Hypermobile Ehlers-Danlos Syndrome co-occurs in 25–50% of POTS patients. Connective tissue laxity promotes venous pooling. Physiotherapy for joint stabilisation is paramount. Compression particularly important. Avoid high-impact exercise. Consider mast cell activation syndrome overlap.
POTS in Pregnancy
POTS often worsens in first trimester (vasodilation, increased HR) then may improve by third trimester. Avoid pharmacological treatment where possible. Increase salt and fluid intake. Compression safe. Midodrine and fludrocortisone should be used with caution — discuss with maternal medicine team.
Adolescent POTS
HR criterion is ≥40 bpm in under-18s. Puberty is a common trigger. Exercise reconditioning is highly effective. School accommodations often needed. Avoid medicalising normal adolescent variation. Most resolve by early adulthood. Parental involvement in education essential.
Monitoring & Review
6–8 weeks
- Repeat active stand test
- Symptom questionnaire (COMPASS-31)
- Review fluid/salt compliance
- Exercise programme progress
- Assess for medication side effects
3 months
- Formal exercise tolerance assessment
- Review subtype classification
- Adjust medications if indicated
- School/work accommodation review
- Mental health screening
6–12 months
- Assess for comorbidities (hEDS, MCAS)
- Consider specialist referral if refractory
- Long-term exercise maintenance plan
- Driving assessment if applicable
- Review and discharge if stable
Prognosis: With appropriate management, the majority of POTS patients achieve meaningful functional improvement within 12 months. Adolescents have the best prognosis — many enter remission by early adulthood. Post-COVID POTS frequently improves over 12–18 months.
Ready to train further?
Explore the full physician training programme — case-based learning, video modules, and clinical pearls from Dr Boon Lim.
Physician Training